| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |